At first, the monovalent influenza A (H5N8) vaccine will be tested in two doses, 21 days apart, in adults aged 18–59.

You’re reading The Checkup With Dr. Wen, a newsletter on how to navigate medical and public health challenges. Click here to ...

The so-called "big, beautiful bill" will lead to millions of fewer people having health coverage in the United States. It will make the country less prepared to detect and respond to a future pandemic ...

HHS Secretary Robert F. Kennedy Jr. and Secretary of Agriculture Brooke Rollins have expressed interest in letting H5N1 ...

Biosafety level (BSL)-3 facilities exist in a diffuse regulatory environment, where requirements depend on factors such as the kinds of pathogens under study, the type of research being conducted, and ...